2011
DOI: 10.1007/s11434-011-4517-9
|View full text |Cite
|
Sign up to set email alerts
|

Special features of the 2009 pandemic swine-origin influenza A H1N1 hemagglutinin and neuraminidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 49 publications
(58 reference statements)
0
12
0
Order By: Relevance
“…These interactions may limit either the movement on inhibitor binding, as shown in typical group 1 NA crystal structures (17,19,20), or the variant conformations in solution, as seen in the molecular dynamics simulations with several group 2 NAs (29,30). In addition, there is still the possibility that the 150-loop of N10 might not be involved in catalysis, whereas the flexible 150-loop in canonical influenza NA might act as an important switch in the catalytic cycle (37).…”
Section: Discussionmentioning
confidence: 99%
“…These interactions may limit either the movement on inhibitor binding, as shown in typical group 1 NA crystal structures (17,19,20), or the variant conformations in solution, as seen in the molecular dynamics simulations with several group 2 NAs (29,30). In addition, there is still the possibility that the 150-loop of N10 might not be involved in catalysis, whereas the flexible 150-loop in canonical influenza NA might act as an important switch in the catalytic cycle (37).…”
Section: Discussionmentioning
confidence: 99%
“…Two major glycoproteins, hemagglutinin (HA) and NA, as well as the M2 ion channel, are on the surface of the virions and are therefore highly accessible targets for drug development 6,7 . Of these three transmembrane proteins, only NA is known to function as an enzyme and is therefore an ideal target for the design of competitive inhibitors that can mimic catalytic transition-state intermediates 8 .…”
mentioning
confidence: 99%
“…By hydrolyzing the bond of terminally linked sialic acid in the influenza virus receptor, NA facilitates the release and migration of virions (7). The nine serotypes of NA from influenza A virus (N1 to N9) have been classified into two groups based upon phylogenetic analysis (group 1 includes N1, N4, N5, and N8; group 2 includes N2, N3, N6, N7, and N9) before the divergent NA-like N10 was identified in bats (8)(9)(10).…”
mentioning
confidence: 99%
“…Crystal structures of seven out of nine of the influenza A virus serotypes have been solved to date (11), leaving N3 and N7 as the last two structure-unknown influenza virus NA serotypes. With the exception of the N1 from the 2009 H1N1 pandemic, all group 1 NAs have contained a 150-cavity adjacent to their active site, formed by the opening of the 150-loop (residues 147 to 150), and all group 2 NA structures have lacked this cavity (7). High-resolution NA structures have led to the successful design and worldwide approval of two NA drugs: oseltamivir and zanamivir (12,13).…”
mentioning
confidence: 99%